Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 4
189
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Noroleanane-type triterpenoids from Dolichos trilobus L. and their anti-α-glucosidase activities

, , , , , , & show all
Pages 600-606 | Received 05 Oct 2018, Accepted 02 Mar 2019, Published online: 31 Mar 2019
 

Abstract

Falcatane A (1) and B (2), 4-oxo-3,24-dinor-2,4-secooleanane- and 3-oxo-24- noroleanane-type triterpenoids, together with seven known triterpenoids involving 2-hydroxy-3-oxo-24-noroleana-1,4,12-trien-28-oic acid (3) and oleanolic acid (4), were separated from the ethyl acetate roots extract of Dolichos trilobus using the column chromatography of silica gel, MCI gel, and Sephadex LH-20. The compounds were determined by analysis of IR, NMR spectroscopic data and mass spectrometry. In the bioassay, all isolates showed varying degree of the α-glucosidase inhibitory activity except compound 2.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the National Natural Science Foundation of China (NSFC No. 81460535, 21262047), the Yunnan Provincial Applied Basic Research Projects (No. 2017FD122), the Yunnan Provincial Department of Education Science Research Fund Projects (No. 2017YJS058).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.